|
시장보고서
상품코드
2076017
SNP 유전자형 분석 및 해석 시장 : 기술별, 용도별, 지역별SNP Genotyping and Analysis Market, By Technology, By Applications, and By Region |
||||||
SNP 유전자형 분석 및 해석 시장은 2026년에 366억 4,000만 달러 규모에 이를 것으로 추정되고 있어 2033년까지 1,482억 5,000만 달러에 이를 것으로 예상되고 있습니다. 2026년부터 2033년까지 CAGR 22.1%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 366억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간 CAGR : | 22.10% | 2033년 시장 규모 예측 : | 1,482억 5,000만 달러 |
DNA 등 개인의 유전 물질에 포함된 단일 염기 다형성(SNP)을 특정하고 분석하는 과정을 SNP 유전자형 분석이라고 합니다. SNP는 인간 유전체에서 확인되는 유전적 변이 중 가장 흔한 것으로, DNA 서열의 특정 위치에서 단일 뉴클레오티드 염기(A, T, C 또는 G)의 변이로 구성됩니다. SNP는 다양한 형질, 질환 및 약물 반응과 관련이 있을 수 있으므로, SNP 유전자형 분석은 유전학 연구에서 중요합니다. 과학자들은 이러한 유전적 변이를 규명하고 연구함으로써, 특정 형질이나 질환을 유발하는 근본적인 유전적 과정에 대한 인사이트를 얻을 수 있습니다. 일반적으로 사용되는 SNP 유전자형 분석법으로는 SNP를 포함하는 DNA 단편을 알려진 SNP 서열을 가진 칩에 하이브리드화시키는 DNA 마이크로어레, 샌거 시퀀싱 및 차세대 시퀀싱(NGS) 기술과 같은 시퀀싱에 기반한 기법이 있습니다. SNP 유전자형 분석 결과는 개인의 유전체 내에 특정 SNP 대립유전자가 존재하는지 여부에 대한 정보를 제공합니다. 이 데이터는 특정 SNP와 형질, 질환 또는 약물 반응 간의 연관성을 조사하는 것은 물론, 집단유전학 연구, 유전적 조상 분석 및 정밀 의학 분야에도 활용될 수 있습니다.
시장 역학
국제 기구가 제공하는 최첨단 SNP 유전자형 분석 서비스의 시작은 분석 기간 동안 시장의 성장을 뒷받침할 것으로 예측됩니다. 예를 들어, 2021년 4월, 전 세계 15곳의 센터를 지원하는 다양한 기여자들이 참여한 전략적 제휴체인 ‘국제농업연구협의그룹(CGIAR)의 육종 우수 프로그램”는 새로운 저비용·고처리량 유전자형 분석 서비스를 발표했습니다. 이를 통해 개발도상국의 육종 프로젝트는 중요한 작물 품종을 제공하는 데 있어 큰 진전을 이룰 수 있게 됩니다. 저밀도 SNP 유전자형 분석 서비스(LDSG)는 육종가들에게 효율적이고 통합적인 서비스를 제공할 뿐만 아니라, 교육 및 지도도 실시했습니다. 이 서비스는 개량 품종 개발을 가속화하고 작물 육종 프로그램을 개선할 잠재력을 지닌 다양한 용도에 대응하고 있습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 SNP 유전자형 분석 및 해석 시장의 주요 기업 프로파일을 소개했습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 SNP 유전자형 분석 및 해석 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 SNP 유전자형 분석 및 해석 시장에 대한 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 SNP 유전자형 분석 및 해석 시장
제5장 세계의 SNP 유전자형 분석 및 해석 시장 : 기술별, 2021-2033년
제6장 세계의 SNP 유전자형 분석 및 해석 시장 : 용도별, 2021-2033년
제7장 세계의 SNP 유전자형 분석 및 해석 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
JHS 26.07.09SNP Genotyping and Analysis Market is estimated to be valued at USD 36.64 Bn in 2026 and is expected to reach USD 148.25 Bn by 2033, growing at a compound annual growth rate (CAGR) of 22.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 36.64 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 22.10% | 2033 Value Projection: | USD 148.25 Bn |
The process of finding and analyzing single nucleotide polymorphisms (SNPs) in an individual's genetic material, such as DNA, is known as SNP genotyping. SNPs are the most prevalent technology of genetic variation identified in the human genome, and they consist of a single nucleotide base (A, T, C, or G) mutation at a specific place in the DNA sequence. SNP genotyping is important in genetic research as SNPs can be linked to a variety of traits, diseases, and drug responses. Scientists can acquire insights into the underlying genetic processes driving specific traits or diseases by identifying and studying these genetic variations. SNP genotyping methods commonly used include DNA microarrays, in which SNP-containing DNA fragments are hybridized to a chip with known SNP sequences, and sequencing-based methods such as Sanger sequencing or next-generation sequencing (NGS) technologies. The results of SNP genotyping provide information about the presence or absence of specific SNP alleles in an individual's genome. This data can be used to investigate the association of specific SNPs with traits, diseases, or drug responses, as well as to conduct population genetics studies, genetic ancestry analysis, and precision medicine applications.
Market Dynamics
Launch of state-of-the-art SNP genotyping services by international organization is anticipated to support the development of the market over the analysis period. For instance, in April 2021, The Consultative Group on International Agricultural Research (CGIAR) Excellence in Breeding program, a strategic alliance of diverse contributors that supports 15 worldwide Centers, announced new low-cost, high-throughput genotyping services, positioning breeding projects in developing countries to make significant strides in delivering critical crop varieties. The Low Density SNP Genotyping Services (LDSG) offer streamlined and centralized services to breeders, as well as training and mentoring. The services provide a variety of applications that have the potential to accelerate the generation of improved varieties and improve crop breeding programs.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global SNP genotyping and analysis market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Nucleome Informatics Private Limited, Azenta Life Sciences, Bio-Rad Laboratories Inc., Danaher Corporation, Douglas Scientific LLC, AllGenetics & Biology SL, Illumina Inc., Life Technologies Corp., Consultative Group on International Agricultural Research, Avance Biosciences, Genotypic Technology Pvt Ltd, Xelect Ltd, Taconic Biosciences, Inc., Luminex Corp., Promega Corporation, CD Genomics, Synbio Technologies, Thermo Fischer Scientific Inc., Sequenom, PREMIER Biosoft, Fluidigm Corporation, Novacyt, Twist Bioscience, Regeneron Pharmaceuticals, Inc, NRGene, and LGC Biosearch Technologies
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, Technology up-gradation, market expansion, and marketing tactics
- Global SNP genotyping and analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global SNP genotyping and analysis market
Detailed Segmentation:
- Global SNP Genotyping and Analysis Market, By Technology (Revenue, USD Bn, 2021 - 2033)
- Polymerase Chain Reaction (PCR)
- Microarray
- Next-Generation Sequencing (NGS)
- Taqman Allelic Discrimination
- Pyrosequencing
- Others
- Global SNP Genotyping and Analysis Market, By Applications (Revenue, USD Bn, 2021 - 2033)
- Diagnostics & Forensics
- Pharmacogenomics
- Agricultural Biotechnology
- Breeding & Animal Livestock
- Global SNP Genotyping and Analysis Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Agilent Technologies Inc.
- Hoffmann-La Roche Ltd
- Nucleome Informatics Private Limited
- Azenta Life Sciences
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Douglas Scientific LLC
- AllGenetics & Biology SL
- Illumina Inc.
- Life Technologies Corp.
- Consultative Group on International Agricultural Research
- Avance Biosciences
- Genotypic Technology Pvt Ltd
- Xelect Ltd
- Taconic Biosciences Inc.
- Luminex Corp.
- Promega Corporation
- CD Genomics
- Synbio Technologies
- Thermo Fischer Scientific Inc.
- Sequenom
- PREMIER Biosoft
- Fluidigm Corporation
- Novacyt
- Twist Bioscience
- Regeneron Pharmaceuticals, Inc
- NRGene
- LGC Biosearch Technologies
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Applications
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Brand Analysis
- PEST Analysis
- Porter€(TM)s Analysis
4. Global SNP Genotyping and Analysis Market
- Overall Impact
- Impact on Supply and Demand
5. Global SNP Genotyping and Analysis Market, By Technology, 2021 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- Polymerase Chain Reaction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Microarray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Next-Generation Sequencing (NGS)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Taqman Allelic Discrimination
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Pyrosequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
6. Global SNP Genotyping and Analysis Market, By Applications, 2021€"2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- Diagnostics & Forensics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Pharmacogenomics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Agricultural Biotechnology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
- Breeding and Animal Livestock
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
7. Global SNP Genotyping and Analysis Market, By Region, 2021€"2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022€"2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€"2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021€"2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nucleome Informatics Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Azenta Life Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Douglas Scientific LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AllGenetics & Biology SL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Illumina Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Life Technologies Corp.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Avance Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genotypic Technology Pvt Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Xelect Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Taconic Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Luminex Corp.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novacyt
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fischer Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Other Prominent Players
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
